Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categories:

265 Episodes

  1. Unraveling Treatment Resistance: A Psychodynamic Approach

    Published: 8/24/2024
  2. Psychedelics: A New Frontier in Psychiatry

    Published: 8/19/2024
  3. Beyond the Prescription Pad: Navigating Patient Ambivalence

    Published: 8/14/2024
  4. Unplugging from Vaping: Cessation Strategies for Teens

    Published: 8/9/2024
  5. When Drugs Don't Work: A Psychodynamic Approach

    Published: 8/4/2024
  6. Rethinking Rx: Benzodiazepines and Suicide Risk

    Published: 7/30/2024
  7. The Psychology of Prescribing: Optimizing Outcomes Through Understanding

    Published: 7/25/2024
  8. ADHD and Pain: A Surprising Link

    Published: 7/20/2024
  9. Restoring Rest: Insomnia Interventions for Depressed Patients

    Published: 7/15/2024
  10. Restoring Sleep in Major Depression: Orexin, Melatonin, and More

    Published: 7/10/2024
  11. Enhancing Pediatric Depression Treatment: The Role of Fish Oil and CBT

    Published: 7/5/2024
  12. Pharmacological Strategies for Insomnia in MDD

    Published: 6/30/2024
  13. Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction

    Published: 6/25/2024
  14. Insomnia and Depression: A Tangled Web

    Published: 6/20/2024
  15. ADHD Treatment During Pregnancy: Insights from Denmark

    Published: 6/15/2024
  16. The Power of Nonpharmacologic Therapies in Fibromyalgia

    Published: 6/10/2024
  17. Highlights From APA 2024: Key Insights on Psychopharmacology

    Published: 6/5/2024
  18. Antidepressants in Pregnancy: Weighing the Evidence

    Published: 5/31/2024
  19. Unraveling the Pharmacological Puzzle of Fibromyalgia

    Published: 5/26/2024
  20. Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa

    Published: 5/21/2024

3 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.